Results 161 to 170 of about 210,178 (301)

Microelimination of hepatitis C in dialysis units: results from the Brazilian Registry for the elimination of HCV. [PDF]

J Bras Nefrol
Abreu PF, Alves PRC, Bittencourt PL, Calvo ICS, Vieira Neto OM, Nascimento MMD, Neves FC, Moura AF, Calazans DCC, Salcedo JMV, Rocha CM, Lobato CMO, França AVC, Pierre AMM, Ferreira ASP, Lopes EP, Medeiros Filho JEM, Souto FJD, Aires RS, Mendes LSC, Uehara SNO, Gonçalves LL, Carmo LPFD, Ivantes CAP, Cheinquer H, Parreira TB, Israel KCSP, Costa VJRC, Sousa HDC, Nasserala JCL, Bastos KA, Pinheiro ME, Silva AQBD, Oliveira CMC, Barros FHS, Dourado MMC, Costa CB, Mothé RA, Cabral AS, Simão DR, Barreto FC, Fraxino PH, Constancio NS, Silva DRD, Silva Filho ÁP, Moura LRR, Machado DJB, Brabo AM, Naseri AP, Carvalho TR, Pestana NDF, Rocha PTMCEA, Lima LMSTB, Perez RM, Narciso-Schiavon JL, Andrade ARCF, Zawadzki B, Moura-Neto JA, Ferraz MLG.   +58 more
europepmc   +1 more source

Infection risk in rheumatoid arthritis patients treated with biologic and targeted therapies

Rheumatology &Autoimmunity, EarlyView.
In this context, infections associated with each biologic and targeted drug are summarized to inform the stratification of RA patients, including the characteristics of the susceptible patients and their concomitant therapy. We aim to provide a benefit‐risk analysis for clinical decision, and vital indications for the prevention of highly correlated ...
Lujing Wang, Jieshi Lin, Jie Qian
wiley   +1 more source

Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan” [PDF]

Clinical and Molecular Hepatology
Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu   +5 more
doaj   +1 more source

Development of a Machine Learning Model to Predict Short Duration HCV Treatment Response. [PDF]

J Viral Hepat
Carson JM, Barbieri S, Verich A, Tu E, Lloyd A, Dore GJ, Matthews GV, Martinello M.   +7 more
europepmc   +1 more source

Hunting as anthropogenic sink of biomass or source of carrion? A brief case study based on German hunting bags

Wildlife Biology, EarlyView.
Dead biomass is a crucial nutrient source for ecosystems. Although hunting residues can subsidize numerous scavenging organisms and are known to drive important zoogeochemical processes at very different scales in the ecosystem, this has received little attention.
Jörg Beckmann, Jörg Müller, Sophie Horlebein, Christian von Hoermann   +3 more
wiley   +1 more source

EuroHePP: The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons. [PDF]

Liver Int
Fondelli S, Arzilli G, da Costa FA, Brixko C, Butí M, Cabezas J, Cocco N, Dawson O, Deogan C, Fischer G, Komorowski A, Meroueh F, Montanari L, Mazzilli S, O'Moore É, Ranieri R, Rigoni R, Saponaro A, Seguin-Devaux C, Salah E, Seyler T, Stöver H, Tavoschi L, Duffell E.   +23 more
europepmc   +1 more source

Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic‐based data

Addiction, Volume 120, Issue 4, Page 745-755, April 2025.
Abstract Aims The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.
Allison M. McFall, Lakshmi Ganapathi, Mihili P. Gunaratne, Aylur K. Srikrishnan, Conjeevaram K. Vasudevan, Santhanam Anand, Sunil S. Solomon, Shruti H. Mehta, Gregory M. Lucas   +8 more
wiley   +1 more source

Cirrhosis Impairs Reconstitution of the Circulating T-Lymphocyte Compartment After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection. [PDF]

United European Gastroenterol J
Paule L, Castillo E, Muñoz L, Martínez J, Fernández C, Miranda A, Lario M, Monserrat J, Ortega MÁ, Calleja JL, Álvarez-Mon M, Albillos A.   +11 more
europepmc   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Acceptability and Effectiveness of Point-of-Care HCV Testing in Low- and Middle-Income Countries: A Systematic Review. [PDF]

Liver Int
Yee WL, Win TM, Draper B, Pham MD, Hellard M, Luchters S.   +5 more
europepmc   +1 more source